{
    "Trade/Device Name(s)": [
        "Hemoglobin Alc",
        "Hemoglobin Alc Calibrators",
        "Hemoglobin Alc Controls"
    ],
    "Submitter Information": "Abbott Laboratories Diagnostics Division",
    "510(k) Number": "K130255",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121291",
        "K052101",
        "K103099"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PDJ",
        "LCP",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "February 20, 2014",
    "Summary Letter Received Date": "February 21, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1373",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Hemoglobin Alc Test System",
        "Calibrator",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Total Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Hemolysate"
    ],
    "Specimen Container(s)": [
        "Dipotassium EDTA tube (plastic)",
        "Lithium heparin tube (plastic)",
        "Sodium heparin tube (plastic)",
        "Sodium Fluoride/Disodium EDTA tube (plastic)",
        "Tripotassium EDTA tube (plastic)"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT c8000 System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay"
    ],
    "Methodologies": [
        "Enzymatic"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott Laboratories Hemoglobin A1c enzymatic assay, calibrators, and controls for quantitative measurement of hemoglobin A1c on the ARCHITECT c8000 System.",
    "Indications for Use Summary": "Quantitative in vitro measurement of percent hemoglobin A1c (NGSP) or HbA1c fraction (mmol/mol, IFCC) in human whole blood and hemolysate on the ARCHITECT c8000 System; used as an aid in the diagnosis of diabetes mellitus, in identifying risk for diabetes, and monitoring long-term blood glucose control.",
    "fda_folder": "Clinical Chemistry"
}